Chicago Partners Investment Group LLC Has $1.09 Million Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Chicago Partners Investment Group LLC increased its stake in HCA Healthcare, acquiring an additional 2,150 shares for a total holding of 3,092 shares valued at approximately $1.09 million.
• Institutional investors own 62.73% of HCA Healthcare's stock, with notable acquisitions from firms like Nuveen LLC and Pacer Advisors increasing their positions significantly in the first quarter.
• HCA Healthcare recently posted earnings of $6.84 EPS, surpassing estimates and showing a 6.4% annual revenue growth, while the company's annual dividend was set at $2.88 with a yield of 0.7%.

Chicago Partners Investment Group LLC increased its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 228.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,092 shares of the company's stock after acquiring an additional 2,150 shares during the quarter. Chicago Partners Investment Group LLC's holdings in HCA Healthcare were worth $1,092,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HCA. Nuveen LLC acquired a new position in shares of HCA Healthcare in the first quarter worth approximately $569,217,000. Pacer Advisors Inc. increased its holdings in HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock worth $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP bought a new stake in HCA Healthcare in the first quarter worth approximately $164,835,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Trading Up 1.6%

Shares of HCA Healthcare stock opened at $433.18 on Tuesday. The stock has a fifty day simple moving average of $411.05 and a 200 day simple moving average of $379.33. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $439.01. The company has a market capitalization of $101.36 billion, a P/E ratio of 18.21, a price-to-earnings-growth ratio of 1.35 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the prior year, the company posted $5.50 earnings per share. HCA Healthcare's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a $0.72 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's payout ratio is currently 12.11%.

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. Weiss Ratings reiterated a "buy (b-)" rating on shares of HCA Healthcare in a report on Wednesday, October 8th. Truist Financial set a $460.00 target price on HCA Healthcare in a research report on Tuesday, October 14th. The Goldman Sachs Group assumed coverage on shares of HCA Healthcare in a report on Tuesday, October 14th. They set a "buy" rating and a $470.00 price objective on the stock. Barclays raised their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the company an "overweight" rating in a research note on Thursday, September 18th. Finally, Jefferies Financial Group raised their price objective on shares of HCA Healthcare from $400.00 to $485.00 in a research note on Wednesday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $437.19.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.